Maximilian Feth, Natasha Weaver, Robert B Fanning, Sung-Min Cho, Matthew J Griffee, Mauro Panigada, Akram M Zaaqoq, Ahmed Labib, Glenn J R Whitman, Rakesh C Arora, Bo S Kim, Nicole White, Jacky Y Suen, Gianluigi Li Bassi, Giles J Peek, Roberto Lorusso, Heidi Dalton, John F Fraser, Jonathon P Fanning
BACKGROUND: Extracorporeal membrane oxygenation (ECMO) is a rescue therapy in patients with severe acute respiratory distress syndrome (ARDS) secondary to COVID-19. While bleeding and thrombosis complicate ECMO, these events may also occur secondary to COVID-19. Data regarding bleeding and thrombotic events in COVID-19 patients on ECMO are sparse. METHODS: Using the COVID-19 Critical Care Consortium database, we conducted a retrospective analysis on adult patients with severe COVID-19 requiring ECMO, including centers globally from 01/2020 to 06/2022, to determine the risk of ICU mortality associated with the occurrence of bleeding and clotting disorders...
May 6, 2024: Journal of Intensive Care